There is no doubt that 2014 is witnessing a revolution in the treatment of hepatitis C. You can find out all the latest information at this year's UEG Week, starting with a dedicated session during the postgraduate teaching programme on Saturday morning (Viral hepatitis: Cure by modern regimens?). The course will further offer you the opportunity to get an update on non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease, as well as on the endoscopic management of malignant biliary obstruction challenges, and will also feature a clinical case-based session on liver function assessments.
For further insights into hepatitis C management, be sure to attend the opening plenary session on Monday morning, which includes a talk by Professor Michael Manns, followed by an overview by Professor Heiner Wedermeyer of what's new in hepatology in clinical practice in 2014. After lunch, there will be a special free paper session on the lingering clinical challenges for hepatitis C therapy, followed by an update symposium on viral hepatitis therapies.
Hepatitis C may be a lead actor in this year's UEG Week liver 'play', but much more besides is being covered. For example, why not join a round table discussion on non-obstructive jaundice on Monday lunchtime (please note that numbers are limited for these sessions)? Updates on NAFLD and liver cirrhosis (in the format of a free paper session and posters in the spotlight) are also featured in the afternoon, in parallel with a session on the immunopathogenesis of pancreatitis and hepatitis, as part of UEG’s two day "Today's Science; Tomorrow's Medicine" initiative.
On Tuesday morning you might find yourself undecided on which session to attend. Will it be 'Clinical management of liver cirrhosis' or 'The liver as a central regulator of inflammation'? Shortly after, there's an update on alcoholic liver disease and novel aspects of biliary tract cancer to choose between. Finally, the afternoon has new concepts in management of biliary diseases and a free paper session on biliary tract cancer occurring simultaneously. Lucky for you, UEG has your back; all recorded sessions will be made available via UEG 24/7, with many of the sessions being made available as they happen, via UEG Week Live.
For the final day of the meeting, there will still be plenty to learn about cholangiocellularcarcinoma (and neuroendocrine tumours), as well as diagnosis and management of both non-cirrhotic and cirrhotic liver nodules. And you may want to return home with some new insights on biliary stenting or on the interconnecting pathways linking viral hepatitis, cytokines and liver regeneration, which you can learn all about in the last two free paper sessions of the day. And don't forget there are poster sessions running throughout the whole meeting!
Last but not least, we invite to visit the online program and search for your specific topic of interest—the word 'liver’ alone returns 355 matches! Or you might want to make use of the UEG Week Vienna Pathways Tool to make sure you’re not missing out! You can also download the UEG Week App for your mobile device and have all this information and more at your fingertips.
We hope you enjoy the hepatobiliary pathway and would love to hear what you find interesting at this year's meeting! Please do comment or tweet to let us know by including one or more of the following hashtags: #UEGWeek #Hepatobiliary #UEGEducation. You can also visit the UEG Education Lounge located in Hall Z and talk to us personally.
Have a great meeting!